September 29, 2022
Yakult Honsha said on September 28 that it has submitted a request to withdraw a new drug application in Japan for its oral phosphoinositide 3-kinase (PI3K) inhibitor duvelisib following discussions with regulatory authorities. The company had filed the application in...read more